tag:blogger.com,1999:blog-9226230.post6005865411727602212..comments2023-10-20T05:43:46.254-07:00Comments on All Allan: Follow-through...or notUnknownnoreply@blogger.comBlogger6125tag:blogger.com,1999:blog-9226230.post-62281661581186912562010-03-22T09:51:55.211-07:002010-03-22T09:51:55.211-07:00"As far as 5 year backtests, markets change a..."As far as 5 year backtests, markets change and trading tactics that work in some markets fail in others. I am completely focused on what is working now in this market environment and its being reflected in just about every chart I have posted in the past six months."<br /><br />The problem is they do change, and you wont know when it happens. Any trading strategy will fail eventually.Anonymousnoreply@blogger.comtag:blogger.com,1999:blog-9226230.post-41226141419485562332010-03-22T08:43:04.345-07:002010-03-22T08:43:04.345-07:00Some of the most profitable trades are in ETF'...Some of the most profitable trades are in ETF's that have only been trading 18 months, so I am not sure what you have tested. In any case, this trend model is working now and has worked for the past 2 years with excellent results. <br /><br />As far as 5 year backtests, markets change and trading tactics that work in some markets fail in others. I am completely focused on what is working now in this market environment and its being reflected in just about every chart I have posted in the past six months.Ahttps://www.blogger.com/profile/04435140994142833427noreply@blogger.comtag:blogger.com,1999:blog-9226230.post-86320938804977273592010-03-22T08:36:19.601-07:002010-03-22T08:36:19.601-07:00Hi Allan,
I have done a backtest using the Modifi...Hi Allan,<br /><br />I have done a backtest using the Modified ATR Trailing Stops from Stocks and Commodities Magazine using the Settings of 7 for Period and 2 for ATR Multiplication on the stocks you have mentioned on a 3 year time frame.<br /><br />The Platform I have used is Esignal.<br /><br />It seems that the strategy has time and time again proven to be unprofitable according to the backtest results shown on my platform.<br /><br />Please clarify how did you obtain your backtest results and what are the entry rules that you use.<br /><br />In addition, I believe the subscribers to your private trade signal should be looking at backtest results of 5 years or more and not just on a 1 year basis as this is too short a timeframe to show the robustness of a system.J Guangnoreply@blogger.comtag:blogger.com,1999:blog-9226230.post-88336077050322829942010-03-22T07:18:59.267-07:002010-03-22T07:18:59.267-07:00Re: Biotech Basket
I added a new core holding, an...Re: Biotech Basket<br /><br />I added a new core holding, another paradigm-changing small cap out of Israel. I will post a complete write-up later this week. In my Weekend Update, I wrote:<br /><br /><i>You wanted to buy Genentech in 1980. Here is your chance.</i><br /><br />AAhttps://www.blogger.com/profile/04435140994142833427noreply@blogger.comtag:blogger.com,1999:blog-9226230.post-47840622663774829112010-03-22T07:09:05.730-07:002010-03-22T07:09:05.730-07:00A post article from manny on the IHub GNVC board h...A post article from manny on the IHub GNVC board he copied off of Yahoo! Thanks manny:<br /><br />“Provisions in the health care bill would not allow generic imitators of bio-tech drugs on the market until after the original drugs have been on sale for 12 years.” <br /><br />- Boston Globe <br />But if you’re a bio-tech company, it’s all going to amount to a colossal victory. <br /><br />Why you ask? <br /><br />Because there’s a provision in both the House and Senate version of the bill that grants a special ‘gift’ to bio-tech companies. <br /><br />A gift that virtually guarantees watershed profits for bio-tech companies for many years to come… <br /><br />So what is it? <br /><br />12 full years of patent protection for any drugs they develop <br />Line <br /><br />Now that might not mean a whole lot to you now- but it should. <br /><br />You see, most conventional drug-makers get 5 years of patent protection for any new drugs they develop. After 5 years, generic versions of the drug are made and the price (and profits) plunge. <br /><br />But not for bio-tech companies... <br /><br />Under the new bill, they get a full 12 years until generics can be made. That’s an extra 7 years of blockbuster profits… <br /><br />Think about that. <br /><br />Pfizer (a conventional drug-maker) gets a new drug approved and gets 5 years until generics are made and the price of the drug plummets. Amgen (or any other bio-tech) gets a new drug approved and gets nearly 2 ½ times longer… <br /><br />I’m not exaggerating when I tell you this is a major turning point for the bio-tech industry. And one you can take all the way to the bank. <br /><br />This bill will serve as a turbo-booster for bio-tech firms that get FDA approval for new drugs and treatments. It definitely raises the stakes... <br /><br />So instead of seeing a bio-tech stock jump 100%-200% as they move through the FDA clinical trial process, we could start seeing 1,000%-5,000% gains instead! <br /><br />Think about what that could do to your portfolio, your bank account… and your life.Anonymousnoreply@blogger.comtag:blogger.com,1999:blog-9226230.post-10146051627321205562010-03-22T07:01:44.962-07:002010-03-22T07:01:44.962-07:00hi Allan,
Any Bio Tech basket for non-subscribers?...hi Allan,<br />Any Bio Tech basket for non-subscribers?Anonymousnoreply@blogger.com